CXCR2 agonist MGTA-145
Term · Oncology and biomedicine · MLC-T-ONC-012844
An agonist of CXC chemokine receptor type 2 (CXCR2), with potential hematopoietic stem cell (HSC) mobilization activity. Upon administration, CXCR2 agonist MGTA-145 binds to and activates CXCR2. This releases matrix metalloproteinase-9 (MMP-9), resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. The HSCs can be collected for autologous and allogeneic stem cell transplantation.
| Identifier | MLC-T-ONC-012844 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | GRO-beta; GROb |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012844",
"term": "CXCR2 agonist MGTA-145",
"field": "Oncology and biomedicine",
"definition": "An agonist of CXC chemokine receptor type 2 (CXCR2), with potential hematopoietic stem cell (HSC) mobilization activity. Upon administration, CXCR2 agonist MGTA-145 binds to and activates CXCR2. This releases matrix metalloproteinase-9 (MMP-9), resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. The HSCs can be collected for autologous and allogeneic stem cell transplantation.",
"synonyms": [
"GRO-beta",
"GROb"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cxcr2-agonist-mgta-145/"
}
Record 5,542 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.